medigraphic.com
SPANISH

Enfermedades Infecciosas y Microbiología

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 2

<< Back Next >>

Enf Infec Microbiol 2013; 33 (2)

Epidemiological overview of leptospirosis, United Mexican States 2000-2010

Zúñiga CIR, Caro LJ
Full text How to cite this article

Language: Spanish
References: 7
Page: 71-76
PDF size: 338.88 Kb.


Key words:

Leptospirosis, epidemiological surveillance, Mexico.

ABSTRACT

In Mexico leptospirosis in humans was not reported in the National Epidemiological Surveillance System (SUIVE in Spanish). It was from 2000 that it began recording consecutive cases.
objective. To describe the epidemiological findings of leptospirosis in Mexico from 2000 to 2010.
method. Through the SUIVE’s information, a transversal descriptive study was made. Principal epidemiological characteristics and predominant serovars are described.
results. The age group most affected was 25 to 44 years old. Regarding the sex distribution of confirmed cases, it was higher in males than in females. The states that had the highest rate of cases were Campeche, Yucatan, Sonora, Oaxaca, Hidalgo, Veracruz, Sinaloa, Tabasco, and Veracruz. October was the month with the highest number of cases. The most common serovars identified were L. bratislava, L. autumnalis, L. canicola, L. ballum, L. hardjo, and L. pomona. A high percentage of the samples were positive for more than one serovar (49.86%).
conclusion. In Mexico leptospirosis cases are more common in tropical regions, predominantly in autumn. The predominant serovars were L. bratislava, L. autumnalis, and L. canicola.


REFERENCES

  1. Colín Ortiz J, Pérez Serna J, Caballero Servín A, García Romero J, Ibarra López L, Cuellar Espinoza J, et al. “Seroprevalencia a leptospiras en un grupo de riesgo de Guadalajara, Jalisco”. Enf Infecc Microbiol 2004; 24: 134-137.

  2. Carrada Figueroa G, Calderón Valencia E, Martínez Hernández C. “Leptospirosis: pleomorfismo clínico en el síndrome febril”. Rev Salud en Tabasco 2002; 8: 128- 132.

  3. Castillo Leal. Seroprevalencia de leptospirosis, en los pacientes solidariohabientes del H.R.S. de Mapastepec, Chiapas. [Tesis de Especialista]. México, Universidad Nacional Autónoma de México, 2001.

  4. Zavala Velázquez J, Vado Solís I, Rodríguez Félix M, Rodríguez Angulo E, Barrera Pérez M, Guzmán Marín E. “Leptospirosis anictérica en un brote epidémico de dengue en la Península de Yucatán”. Rev Biomed 1998; 9: 78-83.

  5. Mateo Balmelli T, Santos Preciado J, Pérez Miravete A., Peña Alonso R. “Leptospirosis ictérica (síndrome de Weil) en un niño con linfoma”. Bol Med Hosp Infant Mex 1996; 53: 411-414.

  6. Velasco-Castrejón O, Rivas Sánchez B, Espinoza Hernández J, Martínez Hernández E. “Diagnosis of chronic leptospirosis, comparison between the microscopic agglutination and three confirmatory diagnostic techniques”. Rev Cubana Med Trop 2007; 59: 8-13.

  7. NOM-029-SSA2-1999, Para la vigilancia epidemiológica, prevención y control de la leptospirosis en el humano.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Enf Infec Microbiol. 2013;33